We are live on ! Find out more
NLVP

New Leaf Venture Partners Portfolio holdings

AUM $43M
1-Year Est. Return 25.55%
This Fund
S&P 500
This Quarter Est. Return
-16.68%
1 Year Est. Return
-25.55%
3 Year Est. Return
+17.13%
5 Year Est. Return
+114.46%
10 Year Est. Return
+1,011.57%
AUM
$334M
AUM Growth
-$126M
Cap. Flow
+$13.3M
Cap. Flow %
3.98%
Top 10 Hldgs %
93.66%
Holding
20
New
1
Increased
1
Reduced
2
Closed
–

Top Buys

Rank Stock Value
1
PASG icon
Passage Bio
PASG
+$39.1M
2
SRRA
Sierra Oncology, Inc. Common Stock
SRRA
+$3.72M

Top Sells

Rank Stock Value
1
PRNB
Principia Biopharma Inc. Common Stock
PRNB
+$28.7M
2
STIM icon
Neuronetics
STIM
+$758K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ARVN icon
1
Arvinas
ARVN
$523M
$92M 27.52%
2,283,048
– –
DCPH
2
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$85.9M 25.7%
2,086,723
– –
PASG icon
3
Passage Bio
PASG
$15.4M
$39.3M 11.77%
+124,896
New +$39.1M
HARP
4
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$33.8M 10.12%
292,141
– –
PRNB
5
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
$25.1M 7.5%
422,214
-492,411
-54% -$28.7M
ALEC icon
6
Alector
ALEC
$167M
$15.4M 4.62%
639,569
– –
APTX
7
DELISTED
Aptinyx Inc. Common Stock
APTX
$7.11M 2.13%
3,290,079
– –
ARAV
8
DELISTED
Aravive, Inc. Common Stock
ARAV
$5.45M 1.63%
946,423
– –
TECX
9
Tectonic Therapeutic
TECX
$580M
$4.91M 1.47%
26,296
– –
SRRA
10
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$4.02M 1.2%
409,611
+284,100
+226% +$3.72M
ITRM
11
DELISTED
Iterum Therapeutics
ITRM
$3.95M 1.18%
97,087
– –
XFOR icon
12
X4 Pharmaceuticals
XFOR
$363M
$3.35M 1%
11,167
– –
NERV icon
13
Minerva Neurosciences
NERV
$198M
$2.71M 0.81%
56,188
– –
CHMA
14
DELISTED
Chiasma, Inc. Common Stock
CHMA
$2.69M 0.8%
735,700
– –
OBSV
15
DELISTED
ObsEva SA Ordinary Shares
OBSV
$2.17M 0.65%
900,501
– –
CRNX icon
16
Crinetics Pharmaceuticals
CRNX
$8.86B
$2.07M 0.62%
141,000
– –
CMRX
17
DELISTED
Chimerix, Inc.
CMRX
$1.94M 0.58%
1,350,000
– –
STIM icon
18
Neuronetics
STIM
$125M
$1.51M 0.45%
796,685
-242,600
-23% -$758K
COGT icon
19
Cogent Biosciences
COGT
$6.83B
$742K 0.22%
448,886
– –
PDSB icon
20
PDS Biotechnology
PDSB
$38.3M
$85K 0.03%
117,242
– –

Similar funds

BAM
Broadcrest Asset Management Winter Park, Florida $44.1M AUM 4.51% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
WCPI
Wynnchurch Capital Partners IV Rosemont, Illinois $44.8M AUM 11.91% 1-Year Est. Return
WAMC
Western Asset Management Company Pasadena, California $45.2M AUM 6.96% 1-Year Est. Return
CC
Corton Capital Carrying Place, Ontario, Canada $40.7M AUM 52.32% 1-Year Est. Return
CIEP
Constellation Investimentos e Participacoes Sao Paulo, Brazil $46.7M AUM 23.3% 1-Year Est. Return
IPI
Inflection Point Investments London, United Kingdom $46.9M AUM 18.35% 1-Year Est. Return
VSAM
Value Star Asset Management Hong Kong $49.2M AUM 60.1% 1-Year Est. Return

New Leaf Venture Partners's Q1 2020 Portfolio in Review

As of Q1 2020, New Leaf Venture Partners held 20 positions worth $334M, down 27% from $460M the previous quarter. Its ten largest holdings account for 94% of the portfolio.

New Leaf Venture Partners deployed $13.3M of net new capital in Q1 2020, opening 1 new position and adding to 1 existing holding. Its largest new stake was Passage Bio: 124,896 shares worth $39.3M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

On the sell side, the largest reduction was Principia Biopharma Inc. Common Stock, an estimated $28.7M trimmed.

  • New Leaf Venture Partners's largest Q1 2020 buy was Passage Bio: 124,896 shares worth $39.3M.
  • New Leaf Venture Partners added most to Sierra Oncology, Inc. Common Stock in Q1 2020, an estimated $3.72M increase.
  • New Leaf Venture Partners's biggest Q1 2020 reduction was Principia Biopharma Inc. Common Stock, cutting an estimated $28.7M.
  • New Leaf Venture Partners's ten largest holdings make up 94% of its $334M portfolio in Q1 2020.
  • New Leaf Venture Partners opened 1 new position and closed 0 in Q1 2020.
  • New Leaf Venture Partners's portfolio value fell 27% quarter-over-quarter to $334M.

Based on New Leaf Venture Partners's 13F filing for Q1 2020, filed 14 May 2020.